Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DIM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109651202B reveals a safe iridium-catalyzed route using dimethyl sulfoxide ylide and CO2, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN103373963B reveals a safer route for pazopanib intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN113845481A details a copper-catalyzed route to pyridazinone intermediates, offering safer alternatives to hydrazine for reliable pharmaceutical manufacturing.
Advanced microchannel synthesis of O-(3-chloro-2-propenyl) hydroxylamine offers high purity and cost reduction in agrochemical intermediate manufacturing for global herbicide production.
Patent CN112812032B reveals a green Rh-catalyzed route using DMC. Offers cost-effective, scalable production of high-purity acetamide intermediates.
Patent CN112812032A reveals a sustainable rhodium-catalyzed route to acetamides using dimethyl carbonate, offering significant cost reduction and supply chain reliability.
Novel catalyst-free N-methylation using formic acid and triethylamine in DMSO. High yields, broad substrate scope, suitable for industrial scale-up of fine chemicals.
Patent CN113089006B details a catalyst-free electrochemical route for 4-seleno-1H-pyrazoles, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112724110B details a novel nickel-catalyzed route for VEGFR inhibitor intermediates, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Discover the novel bis(Amphos) tetrabromo dipalladium complex offering superior stability and catalytic activity for pharmaceutical intermediate manufacturing.
Advanced synthesis of high-purity DMT-Cl via novel catalytic route. Reduces costs in API manufacturing and ensures supply chain stability for nucleoside production.
Patent CN112812032B reveals a green Rh-catalyzed route using dimethyl carbonate. Offers cost-effective, scalable acetamide production for global supply chains.
Patent CN102898327B enables eco-friendly DMAD production using dimethyl carbonate, ensuring supply chain reliability and significant cost savings for pharmaceutical intermediates.
Patent CN103483270B enables high-purity synthesis of agrochemical intermediate with >95% purity through green chemistry principles, eliminating toxic reagents while enhancing supply chain reliability for global herbicide manufacturers.
Patent CN114605476B enables faster production with simplified processing and zero waste generation, enhancing supply chain reliability for catalyst manufacturing.
Solve 2-alkyl quinoline synthesis challenges: 80-92% yield, no anhydrous/oxygen-free, cheap catalysts. Scale with CDMO expertise.
Solve multi-step synthesis challenges with 99.8% yield, 98.1% purity, and no hazardous gas emissions. Reduce production costs and environmental risks for cosmetic and pharmaceutical applications.
Overcome synthesis challenges of trisubstituted allenes with mild reaction conditions, high functional group tolerance, and 70%+ yields. Reduce supply chain risks for API manufacturing.
Discover a 3-step, high-yield synthesis of dimethylorphin phosphate with no chiral resolution. Reduce costs and scale efficiently for your antitussive drug supply chain.
Solve ASC-J9 supply chain challenges with 95% yield, 98.6% purity, and 3h reaction time. CDMO expertise for pharma scale.